West Pharmaceutical Services, Inc. (wst)

WST — Company Overview

West Pharmaceutical Services, Inc. (WST) trades on NYQ as part of the Healthcare peer group (Medical Instruments & Supplies).

WST — Business Description

WST represents a Medical Instruments & Supplies business in the Healthcare segment. West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization pr…

Official website: https://www.westpharma.com.

WST — Investment Thesis

At a high level, WST offers exposure to Healthcare with metrics outlined below from public market data.

• Revenue is expanding at roughly 13.8% year-over-year (public data).
• Trailing P/E of 46.87× implies elevated growth expectations at the current price.
• Forward P/E (37.65×) is below trailing P/E — earnings may be expected to improve.
• Equity market capitalization is approximately $26.45B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

WST — Financial Health

Key financial health indicators for West Pharmaceutical Services, Inc. are derived exclusively from public data — no proprietary estimates.

Profit margin of 17.0% indicates solid bottom-line conversion. Positive free cash flow of $277.94M supports balance-sheet flexibility.

WST — Growth Outlook

Growth outlook for West Pharmaceutical Services, Inc. (WST) depends on demand trends in Medical Instruments & Supplies and the company's ability to convert revenue into sustainable earnings.

• Revenue growth of 13.8% indicates strong top-line momentum.
• Earnings growth of 18.1% year-over-year supports improving profitability.
• Price is 2.6% below the 52-week high.

WST — Competitive Position

West Pharmaceutical Services, Inc. (WST) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

• Competes within Healthcare, specifically in Medical Instruments & Supplies.
• Market capitalization of $26.45B places WST among large-cap peers.
• Gross margin of 36.8% should be benchmarked against direct competitors.

WST — Summary

West Pharmaceutical Services, Inc. (WST) is a large-cap Healthcare company focused on Medical Instruments & Supplies, listed on NYQ. Last price $375.87 with market cap $26.45B. Trailing P/E 46.87×. Revenue grew 13.8% year-over-year per public data. Notable strengths include revenue growth of 13.8% year-over-year. Key watch items include elevated trailing p/e (46.87×) limits valuation margin of safety. Premium Terminal tools for West Pharmaceutical Services, Inc. add ownership analytics, news, and richer estimate history beyond this public summary.